Advisory Services Network’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-200
| Closed | -$49 | – | 4219 |
|
|
2026
Q1 | $49 | Buy |
+200
| New | +$80 | ﹤0.01% | 4761 |
|
|
2025
Q4 | – | Sell |
-200
| Closed | -$135 | – | 3848 |
|
|
2025
Q3 | $135 | Buy |
+200
| New | +$108 | ﹤0.01% | 4287 |
|
|
2024
Q1 | – | Sell |
-1,399
| Closed | -$760 | – | 3292 |
|
|
2023
Q4 | $760 | Buy |
+1,399
| New | +$645 | ﹤0.01% | 3583 |
|
|
2023
Q2 | – | Sell |
-200
| Closed | -$352 | – | 3296 |
|
|
2023
Q1 | $352 | Hold |
200
| – | – | ﹤0.01% | 3787 |
|
|
2022
Q4 | $628 | Buy |
+200
| New | +$776 | ﹤0.01% | 3702 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$2K | – | 2928 |
|
|
2021
Q2 | $2K | Buy |
+200
| New | +$2.26K | ﹤0.01% | 3358 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$3K | – | 2682 |
|
|
2020
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 2916 |
|
|
2020
Q3 | $2K | Buy |
+200
| New | +$2.16K | ﹤0.01% | 3183 |
|
|
2020
Q2 | – | Sell |
-200
| Closed | -$1K | – | 2458 |
|
|
2020
Q1 | $1K | Buy |
+200
| New | +$1.48K | ﹤0.01% | 2933 |
|
|
2019
Q4 | – | Sell |
-6,267
| Closed | -$67K | – | 3233 |
|
|
2019
Q3 | $67K | Hold |
6,267
| – | – | ﹤0.01% | 1241 |
|
|
2019
Q2 | $67K | Hold |
6,267
| – | – | ﹤0.01% | 1239 |
|
|
2019
Q1 | $60K | Sell |
6,267
-184
| -3% | -$1.88K | ﹤0.01% | 1175 |
|
|
2018
Q4 | $74K | Sell |
6,451
-338
| -5% | -$4.2K | 0.01% | 1007 |
|
|
2018
Q3 | $115K | Sell |
6,789
-569
| -8% | -$8.65K | 0.01% | 927 |
|
|
2018
Q2 | $100K | Buy |
7,358
+1,070
| +17% | +$17.8K | 0.01% | 946 |
|
|
2018
Q1 | $119K | Buy |
6,288
+1,885
| +43% | +$40.3K | 0.01% | 961 |
|
|
2017
Q4 | $72K | Buy |
4,403
+4,103
| +1,368% | +$61K | 0.01% | 1108 |
|
|
2017
Q3 | $5K | Hold |
300
| – | – | ﹤0.01% | 1901 |
|
|
2017
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 2023 |
|
|
2017
Q1 | $2K | Buy |
+300
| New | +$1.2K | ﹤0.01% | 1994 |
|
|
2016
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 1915 |
|
|
2016
Q2 | $2K | Buy |
+300
| New | +$1.91K | ﹤0.01% | 1678 |
|
Other funds holding SGMO
AIM
HIG
Advisory Services Network's SGMO Position: Q2 2026 in Review
Advisory Services Network sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 200 shares — an estimated $49 sold.
Advisory Services Network first reported a position in SGMO in Q2 2016 and held it in 22 quarters. The position peaked at $119K in Q1 2018. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.
- Advisory Services Network reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
- Advisory Services Network sold 200 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $49.
- Advisory Services Network first reported a position in SANGAMO THERAPEUTICS INC in Q2 2016 and held it in 22 quarters.
- Advisory Services Network's SANGAMO THERAPEUTICS INC position peaked at $119K in Q1 2018.
- 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.